| scholarly article | Q13442814 |
| P2093 | author name string | Christopher W Cowan | |
| Kimberly M Huber | |||
| Makoto Taniguchi | |||
| Tong Zang | |||
| Laura N Smith | |||
| Brad E Pfeiffer | |||
| Marina A Maksimova | |||
| Julia R Wilkerson | |||
| P2860 | cites work | Advances in autism genetics: on the threshold of a new neurobiology | Q22251023 |
| Postnatal development of the visual cortex and the influence of environment | Q22337285 | ||
| A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation | Q24305050 | ||
| Common genetic variants on 5p14.1 associate with autism spectrum disorders | Q24603204 | ||
| Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. | Q51930328 | ||
| Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function | Q24608468 | ||
| Autism genome-wide copy number variation reveals ubiquitin and neuronal genes | Q24629598 | ||
| Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo | Q24644531 | ||
| MeCP2, a key contributor to neurological disease, activates and represses transcription | Q24647533 | ||
| Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C | Q24649105 | ||
| Identifying autism loci and genes by tracing recent shared ancestry | Q24655308 | ||
| Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes | Q28114892 | ||
| FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association | Q28115097 | ||
| Evidence that fragile X mental retardation protein is a negative regulator of translation | Q28117211 | ||
| Development of the vertebrate neuromuscular junction | Q28141504 | ||
| MEF2: a calcium-dependent regulator of cell division, differentiation and death | Q28215798 | ||
| Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number | Q28297899 | ||
| Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes | Q28303541 | ||
| Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex | Q28307698 | ||
| The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif | Q28348391 | ||
| MEF2C transcription factor controls chondrocyte hypertrophy and bone development | Q28505927 | ||
| MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function | Q28507026 | ||
| Developmental homeostasis of mouse retinocollicular synapses | Q28587961 | ||
| Abnormal development of dendritic spines in FMR1 knock-out mice | Q28589950 | ||
| A simple method for organotypic cultures of nervous tissue | Q29614375 | ||
| The self-tuning neuron: synaptic scaling of excitatory synapses | Q29616059 | ||
| Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function | Q29616372 | ||
| Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. | Q32063419 | ||
| Developmental presence and disappearance of postsynaptically silent synapses on dendritic spines of rat layer 2/3 pyramidal neurons | Q33315224 | ||
| Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines | Q34081296 | ||
| Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice | Q34311517 | ||
| Long-term sensory deprivation prevents dendritic spine loss in primary somatosensory cortex | Q34433739 | ||
| Temporal regulation of the expression locus of homeostatic plasticity. | Q34535800 | ||
| Cocaine regulates MEF2 to control synaptic and behavioral plasticity | Q34818266 | ||
| Neural activity and the dynamics of central nervous system development | Q35719203 | ||
| FMRP RNA targets: identification and validation | Q36228088 | ||
| Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection | Q37070840 | ||
| A point mutation in the FMR-1 gene associated with fragile X mental retardation | Q41579799 | ||
| Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. | Q44124708 | ||
| Biolistic transfection of cultured organotypic brain slices. | Q45992976 | ||
| Fragile X mental retardation protein induces synapse loss through acute postsynaptic translational regulation. | Q48232839 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 191-197 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Neuron | Q3338676 |
| P1476 | title | Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. | |
| P478 | volume | 66 |
| Q64278585 | A Late Phase of Long-Term Synaptic Depression in Cerebellar Purkinje Cells Requires Activation of MEF2 |
| Q33756913 | A role for dendritic mGluR5-mediated local translation of Arc/Arg3.1 in MEF2-dependent synapse elimination |
| Q57292383 | Activation of autophagy rescues synaptic and cognitive deficits in fragile X mice |
| Q35228888 | Activity-dependent FMRP requirements in development of the neural circuitry of learning and memory |
| Q38074584 | Activity-dependent neuronal signalling and autism spectrum disorder |
| Q90251211 | Antagonizing Increased miR-135a Levels at the Chronic Stage of Experimental TLE Reduces Spontaneous Recurrent Seizures |
| Q50313859 | Association and Promoter Analysis of AVPR1A in Finnish Autism Families. |
| Q27320813 | Autism-Associated Chromatin Regulator Brg1/SmarcA4 Is Required for Synapse Development and Myocyte Enhancer Factor 2-Mediated Synapse Remodeling |
| Q41477199 | Cdk5-dependent phosphorylation of liprinα1 mediates neuronal activity-dependent synapse development |
| Q27022703 | Channelopathies and dendritic dysfunction in fragile X syndrome |
| Q36120228 | Crystal structure reveals specific recognition of a G-quadruplex RNA by a β-turn in the RGG motif of FMRP. |
| Q26851661 | Defining the RGG/RG motif |
| Q88535420 | Dendritic Spine Elimination: Molecular Mechanisms and Implications |
| Q41691925 | Distinct stages of synapse elimination are induced by burst firing of CA1 neurons and differentially require MEF2A/D |
| Q38116091 | Emerging roles for MEF2 transcription factors in memory |
| Q35003579 | Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome. |
| Q47132310 | Experience-Dependent and Differential Regulation of Local and Long-Range Excitatory Neocortical Circuits by Postsynaptic Mef2c |
| Q39063317 | FMRP-dependent Mdm2 dephosphorylation is required for MEF2-induced synapse elimination |
| Q40220770 | FMRP: a triple threat to PSD-95. |
| Q47657806 | Fragile X Mental Retardation Protein Requirements in Activity-Dependent Critical Period Neural Circuit Refinement. |
| Q36928564 | Fragile X mental retardation protein regulates new neuron differentiation in the adult olfactory bulb |
| Q27302324 | Fragile X mental retardation protein regulates olfactory sensitivity but not odorant discrimination |
| Q33738812 | Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration |
| Q37900184 | Fragile X-associated disorders: a clinical overview. |
| Q39301735 | From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms |
| Q37958909 | From filopodia to synapses: the role of actin-capping and anti-capping proteins. |
| Q29416996 | Genome-wide association analysis identifies susceptibility loci for migraine without aura |
| Q37564195 | Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models |
| Q28508411 | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival |
| Q34435526 | Increasing our understanding of human cognition through the study of Fragile X Syndrome |
| Q36518325 | Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles |
| Q34289505 | Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms |
| Q27023529 | Interactions between mitochondria and the transcription factor myocyte enhancer factor 2 (MEF2) regulate neuronal structural and functional plasticity and metaplasticity |
| Q28079060 | LTD-like molecular pathways in developmental synaptic pruning |
| Q39235784 | Long-term depression-associated signaling is required for an in vitro model of NMDA receptor-dependent synapse pruning. |
| Q28246677 | Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits |
| Q48411990 | MEF2 negatively regulates learning-induced structural plasticity and memory formation |
| Q52626735 | MEF2A regulates mGluR-dependent AMPA receptor trafficking independently of Arc/Arg3.1. |
| Q37172192 | MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways |
| Q30370553 | MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders. |
| Q43899926 | MHCI promotes developmental synapse elimination and aging-related synapse loss at the vertebrate neuromuscular junction |
| Q37128147 | MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease |
| Q37870324 | Making and breaking synapses through local mRNA regulation |
| Q33874584 | Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome |
| Q28081179 | Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development |
| Q24306675 | Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95 |
| Q90631344 | Myocyte Enhancer Factor 2A (MEF2A) Defines Oxytocin-Induced Morphological Effects and Regulates Mitochondrial Function in Neurons |
| Q92668133 | Neuronal Myocyte-Specific Enhancer Factor 2D (MEF2D) Is Required for Normal Circadian and Sleep Behavior in Mice |
| Q34183712 | Neuronal activity-regulated gene transcription in synapse development and cognitive function |
| Q37251865 | Neuronal autophagy and neurodevelopmental disorders |
| Q34159122 | Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain |
| Q89295073 | Postsynaptic FMRP Regulates Synaptogenesis In Vivo in the Developing Cochlear Nucleus |
| Q37025074 | Postsynaptic FMRP bidirectionally regulates excitatory synapses as a function of developmental age and MEF2 activity. |
| Q38736600 | Posttranslational Modifications Regulate the Postsynaptic Localization of PSD-95. |
| Q37899389 | Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins |
| Q37986650 | Regulation of the actin cytoskeleton in dendritic spines |
| Q41991920 | Remodeling of dendrites and spines in the C1q knockout model of genetic epilepsy |
| Q45028815 | Rescue of Synaptic Phenotypes and Spatial Memory in Young Fragile X Mice |
| Q42457098 | Reversal of activity-mediated spine dynamics and learning impairment in a mouse model of Fragile X syndrome |
| Q92801198 | Reward-Related Expectations Trigger Dendritic Spine Plasticity in the Mouse Ventrolateral Orbitofrontal Cortex |
| Q47752204 | Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease |
| Q27666251 | Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction |
| Q37086805 | Sumoylated MEF2A coordinately eliminates orphan presynaptic sites and promotes maturation of presynaptic boutons. |
| Q48646891 | Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons. |
| Q37289487 | Synapse maturation by activity-dependent ectodomain shedding of SIRPα. |
| Q57267880 | Synaptic Disorders |
| Q26745117 | Synaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X Syndrome |
| Q60938189 | Synaptopathology Involved in Autism Spectrum Disorder |
| Q47989366 | The Cadherin Superfamily in Neural Circuit Assembly |
| Q38080479 | The MEF2 family and the brain: from molecules to memory |
| Q42183498 | The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome. |
| Q34775116 | The role of Cdk5 in cognition and neuropsychiatric and neurological pathology |
| Q55314869 | The transcription factor MEF2A plays a key role in the differentiation/maturation of rat neural stem cells into neurons. |
| Q35614072 | Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond |
| Q39296630 | Transcribing the connectome: roles for transcription factors and chromatin regulators in activity-dependent synapse development |
| Q34222337 | Transcriptional regulation of neuronal polarity and morphogenesis in the mammalian brain |
| Q38777978 | Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops |
| Q26864720 | Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders |
| Q35230774 | Visual sensorial impairments in neurodevelopmental disorders: evidence for a retinal phenotype in Fragile X Syndrome |
Search more.